TG Therapeutics, Inc. (TGTX)

NCM – Real Time Price. Currency in USD

42.54

-0.60 (-1.39%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

616M

329M

234M

Cost of goods sold

-101M

-39M

-15M

-780K

Gross Profit

516M

290M

219M

Operating expenses (excl. COGS)

-392M

-248M

-198M

-195M

Operating Income

123M

42M

21M

-193M

Non-operating income, total

-16M

-8M

-5M

Pretax income

107M

26M

13M

-198M

Equity in earnings

Taxes

340M

-2M

-390K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

447M

23M

13M

-198M

TG Therapeutics, Inc. (TGTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TG Therapeutics, Inc. (TGTX)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

TG Therapeutics, Inc. (TGTX)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

TG Therapeutics, Inc. (TGTX)

Income Statement (Annual)

Income Statement (Annual)